NOVAVAX INC Total Assets
NOVAVAX INC (NVAX) had Total Assets of $955.58 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets
us-gaap:Assets · last filed 2026-08-06
- 2026-06-30: Assets $955.58M.
- 2026-03-31: Assets $1.04B.
- 2025-12-31: Assets $1.18B.
- 2025-09-30: Assets $1.18B.
| Period end | Assets | Assets as first filed |
|---|---|---|
| 2026-06-30 | $955.58M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $1.04B 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $1.18B 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $1.18B 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $1.34B 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $1.29B 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $1.56B 10-K · filed 2026-02-26 | |
| 2024-09-30 | $1.71B 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $1.82B 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $1.35B 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $1.80B 10-K · filed 2025-02-27 | |
| 2023-09-30 | $1.66B 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $1.69B 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $1.54B 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $2.26B 10-K · filed 2024-02-28 | |
| 2022-09-30 | $2.27B 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $2.62B 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $2.83B 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $2.58B 10-K · filed 2023-02-28 | |
| 2021-09-30 | $2.57B 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $2.75B 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $2.61B 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $1.58B 10-K · filed 2022-03-01 | |
| 2020-09-30 | $944.02M 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $932.23M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $328.07M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $172.96M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $164.81M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $189.39M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $221.32M 10-Q · filed 2019-05-02 | |
| 2018-12-31 | $207.98M 10-K · filed 2020-03-11 | |
| 2018-09-30 | $250.48M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $285.81M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $276.07M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $302.49M 10-K · filed 2019-03-18 | |
| 2017-09-30 | $334.08M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $355.71M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $361.50M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $394.30M 10-K · filed 2018-03-14 | |
| 2016-09-30 | $459.63M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $525.00M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $592.51M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $386.04M 10-K · filed 2017-02-27 | |
| 2015-09-30 | $404.63M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $424.70M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $438.84M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $276.00M 10-K · filed 2016-02-29 | |
| 2014-09-30 | $292.51M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $311.99M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $218.60M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $235.13M 10-K · filed 2015-02-27 | $235.94M 10-K · filed 2014-03-12 |
| 2013-09-30 | $245.07M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $92.92M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $98.70M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $102.34M 10-K · filed 2014-03-12 | |
| 2012-09-30 | $80.55M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $76.98M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $68.64M 10-Q · filed 2012-05-09 | |
| 2011-12-31 | $66.58M 10-K · filed 2013-03-12 | |
| 2011-09-30 | $67.08M 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $69.35M 10-Q · filed 2011-08-09 | |
| 2010-12-31 | $74.84M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |